Published in BMC Neurol on January 22, 2016
A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol (1994) 30.72
The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med (1975) 13.82
Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc (2002) 8.28
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis (2008) 7.17
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 5.82
Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am (1984) 4.63
Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J (2004) 4.41
What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr (1987) 4.21
Sarcopenia: origins and clinical relevance. J Nutr (1997) 3.88
Outcome and time course of recovery in stroke. Part II: Time course of recovery. The Copenhagen Stroke Study. Arch Phys Med Rehabil (1995) 3.50
Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) (2000) 3.31
Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness. Phys Ther (1984) 3.27
Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr (1985) 3.10
Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. Am J Clin Nutr (2003) 2.65
Clinical interpretation and use of stroke scales. Lancet Neurol (2006) 2.58
Localized bioimpedance analysis in the evaluation of neuromuscular disease. Muscle Nerve (2002) 2.54
Investigation of a new motor assessment scale for stroke patients. Phys Ther (1985) 2.18
The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud (1992) 2.03
The German hospital malnutrition study. Clin Nutr (2006) 1.93
Assessment of motor function in stroke patients. Physiotherapy (1979) 1.90
Fugl-Meyer assessment of sensorimotor function after stroke: standardized training procedure for clinical practice and clinical trials. Stroke (2010) 1.83
Overview of the MNA--Its history and challenges. J Nutr Health Aging (2006) 1.65
Bioelectric impedance phase angle and body composition. Am J Clin Nutr (1988) 1.50
Effects of flooding amino acids on incorporation of labeled amino acids into human muscle protein. Am J Physiol (1998) 1.47
The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle (2012) 1.35
The development of new research methods for the valuation of EQ-5D-5L. Eur J Health Econ (2013) 1.32
Body weight after stroke: lessons from the obesity paradox. Stroke (2011) 1.31
Physiopathological mechanism of sarcopenia. J Nutr Health Aging (2009) 1.27
Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev (2012) 1.26
Effect of amino acid supplementation on muscle mass, strength and physical function in elderly. Clin Nutr (2008) 1.26
Changes in muscle mass, fat mass, and bone mineral content in the legs after stroke: a 1 year prospective study. Bone (2001) 1.19
Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management. J Cachexia Sarcopenia Muscle (2014) 1.16
Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur Heart J (2012) 1.09
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. Eur Heart J (2012) 1.08
Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc (2015) 1.07
A review of the relationship between dysphagia and malnutrition following stroke. J Rehabil Med (2009) 1.06
Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review. J Am Med Dir Assoc (2012) 1.03
The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing (2013) 1.02
Exercise, amino acids, and aging in the control of human muscle protein synthesis. Med Sci Sports Exerc (2011) 1.00
Longitudinal changes in muscle strength and mass after acute stroke. Cerebrovasc Dis (2006) 0.99
Assessing skeletal muscle mass: historical overview and state of the art. J Cachexia Sarcopenia Muscle (2014) 0.97
Stroke induced Sarcopenia: muscle wasting and disability after stroke. Int J Cardiol (2013) 0.95
Sarcopenia in stroke-facts and numbers on muscle loss accounting for disability after stroke. J Cachexia Sarcopenia Muscle (2011) 0.90
Stroke-related sarcopenia: specific characteristics. J Am Med Dir Assoc (2015) 0.90
Catabolic signaling and muscle wasting after acute ischemic stroke in mice: indication for a stroke-specific sarcopenia. Stroke (2014) 0.88
Effect of essential amino acid supplementation on quality of life, amino acid profile and strength in institutionalized elderly patients. Clin Nutr (2011) 0.85
Clinical use of amino acids as dietary supplement: pros and cons. J Cachexia Sarcopenia Muscle (2011) 0.84
Body composition assessed by anthropometry and bioelectric impedance analysis in older persons recovering from cerebrovascular accident. Int J Vitam Nutr Res (2003) 0.81
The bioimpedance phase angle predicts low muscle strength, impaired quality of life, and increased mortality in old patients with cancer. J Am Med Dir Assoc (2014) 0.81
Protective overweight in cardiovascular disease: moving from 'paradox' to 'paradigm'. Eur Heart J (2015) 0.80
Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): a protocol for a randomised controlled trial. BMC Neurol (2013) 0.78
Sarcopenia: there is a need for some steps forward. J Am Med Dir Assoc (2014) 0.78